Gilyazova, Irina,
Ivanova, Elizaveta,
Gupta, Himanshu,
Mustafin, Artur,
Ishemgulov, Ruslan,
Izmailov, Adel,
Gilyazova, Gulshat,
Pudova, Elena,
Pavlov, Valentin,
Khusnutdinova, Elza (2023) to late-stage tissues. Remarkably, for a combination of three miRNAs, PSA levels and Gleason
scores were
Torokulova, Karlygach T.,
Biyalieva, Gulmira S.,
Akulich, Elena N.,
Mamytova, Elmira A.,
Mamytova, Aina J.,
Akhmadeeva, Leila R. (2024) were D-dimer level, age, sex, lower limb plegia, and high NIHHS
scores. Conclusion: Identification
Kan, Xiu,
Fan, Yixuan,
Zheng, Jinjie,
Kudreyko, Aleksey,
Chi, Chi-hung,
Song, Wanqing,
Tregubova, Albina (2023) method suggests to use group users by targeting malicious users with typical malicious features. The Z-
scoreBikbov, Mukharram M.,
Kazakbaeva, Gyulli M.,
Rakhimova, Ellina M.,
Panda-Jonas, Songhomitra,
Tuliakova, Azaliia M.,
Fakhretdinova, Albina A.,
Jonas, Jost B. (2025) disease (OR: 1.67), higher stage of arterial hypertension (OR: 1.15), and higher depression
score (OR: 1
Valeeva, Diana,
Akhiiarova, Karina,
Minniakhmetov, Ildar,
Mokrysheva, Natalia,
Khusainova, Rita,
Tyurin, Anton (2025) that the number of fractures correlated with BMD in absolute values but not with the Z-
score. Conclusions
Balkhiyarova, Z.,
Luciano, R.,
Kaakinen, M.,
Ulrich, A.,
Shmeliov, A.,
Bianchi, M.,
Chioma, L.,
Dallapiccola, B.,
Prokopenko, I.,
Manco, M. (2022) part of the genetic background. We aimed to test if weighted genetic risk
scores (GRSs) for T2D